Interference of uzara glycosides in assays of digitalis glycosides

International Journal of Clinical Pharmacology and Therapeutics

Volumn 42, Issue 5, 2004, Pages 281-284

  Thurmann P A ^a   Neff, A ^a   Fleisch, J ^b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b Kliniken St Antonius   (Germany)

Author keywords

Adverse reaction; Digitals glycosides; Interference; Uzara glycosides

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIARRHEAL AGENT; CAPTOPRIL; DIGITALIS GLYCOSIDE; DIGITOXIGENIN; DIGITOXIN; DIGOXIN; FUROSEMIDE; HEPARIN; HERBACEOUS AGENT; NON PRESCRIPTION DRUG; PLANT GLYCOSIDE; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; UZARA GLYCOSIDE; UZARIGENIN;

ADULT; AGED; ARTICLE; CARDIOVERSION; CASE REPORT; CONTROLLED STUDY; DIARRHEA; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG CONTRAINDICATION; DRUG DETERMINATION; DRUG HALF LIFE; DRUG INDICATION; DRUG INFORMATION; DRUG MANUFACTURE; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PILOT STUDY; RESPIRATORY DISTRESS; SINGLE DRUG DOSE; VOLUNTEER;

EID: 2542485465     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP42281     Document Type: Article

References (14)

1. Brown L, Erdmann E, Thomas R 1983 Digitalis structure-activity relationship analysis. Biochem Pharmacol 32: 2767-2774
2. Derendorf H, Garrett ER 1987 Pharmakokinetik. Wissenschafliche Verlagsgesellschaft, Stuttgart, pp 17
3. Geßner O 1961 Entwicklung und Praxis der Uzaratherapie. Med Klin 56: 1492-1496
4. Grüber A 1920 Uzara. Therapeutische Halbmonatshefte 17: 465-470
5. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG 1996 Goodman and Gilman's: The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, pp 1736
6. Jortani SA, Helm RA, Johnson NJ, Valdes R Jr 1997 Interference of Uzara (an antidiarrheal medication) in digoxin immunoassays. Ther Drug Monit 19: 57 (Abstract 110)
7. Miller LG 1998 Herbal medicinals. Selected clinical considerations focusing on known or potential herb-drug interactions. Arch Intern Med 158: 2200-2211
8. Montag C 1951 Über Uzarawirkung auf den Verdauungstrakt. Ther Gegenw 2: 58-60
9. Schmitz B, El Agamy R, Lindner K 1992 Uzarawurzel - seit 80 Jahren bewährt bei akuten Durchfallerkrankungen. Pharm Z 137: 1697-1713
10. Summary of Product Characteristics (SPC) 2002 Uzara. NIDDApharm GmbH, Bad Vilbel, Germany
11. Summary of Product Characteristics 1999 CEDIA Digitoxin-Test. Roche Diagnostics GmbH, Mannheim
12. Summary of Product Characteristics 1999 Tina-quant Digoxin Test. Roche Diagnostics GmbH, Mannheim
13. Watt JM 1930 The pharmacology of Xysmalobium. J Pharmacol 38: 261-270
14. Watt JM 1935 The uses and actions of Xysmalobium undulatum. S Afr J Med Sci 1: 4-11